Pharma

Drug makers and biotechs, from the research on new molecules to the sale of generics. Growth comes from clinical trial results, regulatory approvals and patents, and is lost when a leading drug's exclusivity expires. Sensitive to drug pricing policy, to reimbursement decisions and to the cost of financing long research programmes.